Philip H Elsinga Selected Research

Philip H Elsinga Research Topics

Disease

44	Neoplasms (Cancer) 05/2022 - 02/2002
9	Inflammation (Inflammations) 01/2021 - 04/2004
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 08/2011
8	Glioma (Gliomas) 02/2014 - 04/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2021 - 09/2008
3	Melanoma (Melanoma, Malignant) 03/2022 - 12/2003
3	Atherosclerotic Plaque (Atheroma) 04/2020 - 01/2013
3	Cognitive Dysfunction 01/2018 - 08/2011
3	Neoplasm Metastasis (Metastasis) 01/2006 - 12/2003
2	Carcinoma (Carcinomatosis) 03/2022 - 12/2005
2	Brain Diseases (Brain Disorder) 12/2021 - 03/2008
2	Asthma (Bronchial Asthma) 01/2021 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 07/2004
2	Epilepsy (Aura) 01/2018 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 10/2014
2	Atherosclerosis 12/2015 - 01/2013
2	Memory Disorders (Memory Loss) 06/2015 - 08/2011
2	Sleep Deprivation 06/2015 - 04/2015
2	Neuroinflammatory Diseases 05/2014 - 03/2012
2	Islet Cell Adenoma (Islet Cell Tumors) 05/2012 - 03/2008
2	Laryngeal Neoplasms (Laryngeal Cancer) 12/2009 - 02/2004
2	Schizophrenia (Dementia Praecox) 07/2009 - 01/2004
2	Carcinoid Tumor (Carcinoid) 03/2008 - 09/2006
1	Neurobehavioral Manifestations 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Carcinogenesis 01/2021

Drug/Important Bio-Agent (IBA)

12	LigandsIBA 10/2015 - 11/2004
11	RadiopharmaceuticalsIBA 01/2021 - 02/2002
9	sigma Receptors (sigma Receptor)IBA 10/2015 - 11/2004
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017 - 02/2004
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2008
6	Pharmaceutical PreparationsIBA 01/2022 - 11/2004
6	SA 4503IBA 06/2015 - 11/2004
5	Bombesin Receptors (Bombesin Receptor)IBA 01/2017 - 08/2011
5	BombesinIBA 01/2017 - 08/2011
5	GlucuronidaseIBA 11/2012 - 05/2010
5	alovudineIBA 01/2011 - 02/2004
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 01/2010
4	EnzymesIBA 09/2021 - 05/2010
4	Proteins (Proteins, Gene)FDA Link 04/2017 - 12/2005
4	fluorodopa F 18IBA 01/2015 - 09/2006
4	Peptides (Polypeptides)IBA 10/2013 - 08/2011
4	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2008 - 01/2004
3	Matrix Metalloproteinases (MMPs)IBA 10/2015 - 01/2013
3	Sigma-1 ReceptorIBA 06/2015 - 08/2011
3	ProdrugsIBA 11/2012 - 05/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2012 - 09/2006
3	TurpentineIBA 03/2012 - 04/2004
3	Haloperidol (Haldol)FDA LinkGeneric 12/2008 - 11/2004
2	AntibodiesIBA 03/2022 - 05/2021
2	Dopamine (Intropin)FDA LinkGeneric 09/2021 - 09/2015
2	Amino Acids FDA Link 09/2021 - 01/2008
2	AzidesIBA 04/2021 - 08/2020
2	Alkynes (Acetylenes)IBA 04/2021 - 08/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 04/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2019 - 08/2011
2	Antineoplastic Agents (Antineoplastics)IBA 10/2015 - 01/2010
2	Adenosine (Adenocard)FDA LinkGeneric 05/2014 - 08/2011
2	Propranolol (Inderal)FDA LinkGeneric 02/2014 - 03/2008
2	bombesin (7-14)IBA 10/2013 - 08/2011
2	Technetium (Technetium 99m)IBA 10/2013 - 08/2011
2	tricineIBA 10/2013 - 08/2011
2	rimcazoleIBA 09/2013 - 12/2008
2	Cytostatic AgentsIBA 11/2012 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2012 - 03/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2011 - 09/2006
2	CatecholaminesIBA 10/2009 - 03/2008
2	Carbidopa (Lodosyn)FDA LinkGeneric 09/2008 - 09/2006
2	Phenylalanine (L-Phenylalanine)FDA Link 09/2008 - 03/2008
2	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2008 - 09/2006
2	Choline (Choline Chloride)IBA 01/2008 - 02/2002
2	NucleosidesIBA 01/2008 - 04/2004
2	1- (4- 2'- fluoroethoxy- 3- methoxyphenethyl)- 4- (3- (4- fluorophenyl)propyl)piperazineIBA 01/2006 - 11/2004
2	ThymidineIBA 04/2004 - 12/2003
1	Therapeutic UsesIBA 04/2022
1	IsotopesIBA 03/2022
1	Epithelial Cell Adhesion MoleculeIBA 03/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2022
1	AntigensIBA 03/2022
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022
1	Histamine AgonistsIBA 01/2022
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 01/2022
1	CanagliflozinIBA 11/2021
1	Sodium-Glucose Transport ProteinsIBA 11/2021
1	Carboxy-LyasesIBA 09/2021
1	Alanine (L-Alanine)FDA Link 09/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	ArginaseIBA 01/2021
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	enzalutamideIBA 01/2021
1	LipidsIBA 04/2020

Therapy/Procedure

12	Therapeutics 05/2021 - 12/2003
4	Drug Therapy (Chemotherapy) 11/2012 - 09/2006
3	Immunotherapy 05/2022 - 01/2018
3	Radiotherapy 10/2013 - 12/2009
1	Secondary Prevention 04/2020